GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioArctic AB (STU:B9A) » Definitions » Research & Development

BioArctic AB (STU:B9A) Research & Development : €5.57 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is BioArctic AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. BioArctic AB's Research & Development for the three months ended in Mar. 2024 was €5.57 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €5.57 Mil.

BioArctic AB Research & Development Historical Data

The historical data trend for BioArctic AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioArctic AB Research & Development Chart

BioArctic AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only - - - - -

BioArctic AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.22 - - - 5.57

BioArctic AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €5.57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioArctic AB  (STU:B9A) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

BioArctic AB Research & Development Related Terms

Thank you for viewing the detailed overview of BioArctic AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

BioArctic AB (STU:B9A) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioArctic AB (STU:B9A) » Definitions » Research & Development
Comparable Companies
OSTO:CAMX OSTO:CALTX OSTO:GENO OSTO:VICO OSTO:EGTX OSTO:HNSA OSTO:IBT B OSTO:FLUO OSTO:BINV OSTO:XSPRAY OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
BRCTF:USA BIOA B:Sweden 0RV2:UK B9A:Germany
Address
Warfvinges vag 35, Stockholm, SWE, SE-112 51
Website
https://www.bioarctic.se
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.

BioArctic AB (STU:B9A) Headlines

No Headlines